← back to search

Pär Stattin

Uppsala University · SE
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Cancer Risks and Factors, and Cancer, Lipids, and Metabolism.
h-index
92
citations
27,955
works
691
NIH funding
primary concept
email

Recent publications

Body mass index and risk of over 100 cancer forms and subtypes in 4.1 million individuals in Sweden: the Obesity and Disease Development Sweden (ODDS) pooled cohort study
The Lancet Regional Health - Europe 2024cited by 41position: middledoi
Prognosis of Gleason Score 9–10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study
European Urology Oncology 2023cited by 23position: middledoi
Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis
International Journal of Epidemiology 2022cited by 55position: middledoi
Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia
International Journal of Cancer 2022cited by 50position: middledoi
Prostate cancer polygenic risk score and prediction of lethal prostate cancer
npj Precision Oncology 2022cited by 47position: middledoi
Epidemiology and Prevention of Prostate Cancer
European Urology Oncology 2021cited by 598position: middledoi
An Aggregated Comorbidity Measure Based on History of Filled Drug Prescriptions: Development and Evaluation in Two Separate Cohorts
Epidemiology 2021cited by 45position: middledoi
Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic
PLoS ONE 2021cited by 20position: lastdoi
The 90‐day cause‐specific mortality after radical prostatectomy: a nationwide population‐based study
British Journal of Urology 2021cited by 8position: middledoi
Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study
PLoS ONE 2020cited by 41position: lastdoi
Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study
European Urology 2019cited by 137position: middledoi
The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF‐I, IGF‐II, IGFBP‐1, IGFBP‐2 and IGFBP‐3 in a pooled analysis of 16,024 men from 22 studies
International Journal of Cancer 2019cited by 32position: middledoi
Androgen deprivation therapy for prostate cancer and risk of dementia
British Journal of Urology 2019cited by 31position: middledoi
A nutrient-wide association study for risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition and the Netherlands Cohort Study
European Journal of Nutrition 2019cited by 17position: middledoi
Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies
European Urology 2018cited by 121position: middledoi
Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review
European Urology 2018cited by 111position: middledoi
Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population‐based study
International Journal of Cancer 2018cited by 88position: lastdoi
Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study
International Journal of Cancer 2018cited by 51position: middledoi
Defining Intermediate Risk Prostate Cancer Suitable for Active Surveillance
The Journal of Urology 2018cited by 32position: lastdoi
A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus
ecancermedicalscience 2018cited by 30position: middledoi
A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0
PLoS ONE 2018cited by 22position: middledoi
Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies
Duo Research Archive (University of Oslo) 2018cited by 0position: middle
Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study
BMC Medicine 2017cited by 83position: middledoi
Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study
European Urology 2017cited by 52position: lastdoi
Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men
PLoS ONE 2017cited by 47position: middledoi
Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)
International Journal of Cancer 2017cited by 42position: middledoi
Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE5Is) and Risk of Melanoma
JNCI Journal of the National Cancer Institute 2017cited by 32position: lastdoi
Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study
European Urology 2017cited by 30position: lastdoi
Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden
JAMA Oncology 2016cited by 167position: lastdoi
A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk
Cancer Research 2016cited by 163position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hans Garmo · Uppsala University25 papers (2012–2023)David Robinson · Skåne University Hospital20 papers (2013–2021)Stacy Loeb · Institute of Population and Public Health17 papers (2013–2021)Lars Holmberg · Uppsala University14 papers (2012–2021)Mieke Van Hemelrijck · Guy's Hospital13 papers (2012–2019)Jan Adolfsson · Karolinska Institutet12 papers (2012–2019)Yasin Folkvaljon · New York University12 papers (2013–2018)Ola Bratt · Cambridge University Hospitals NHS Foundation Trust12 papers (2012–2019)Lars Egevad · Karolinska Institutet9 papers (2014–2023)Mats Lambe · Karolinska Institutet8 papers (2012–2021)Olof Akre · Karolinska Institutet8 papers (2012–2021)Anna Bill‐Axelson · Uppsala University8 papers (2012–2018)Christel Häggström · Umeå University7 papers (2012–2024) · 5 papers (2014–2016) · 5 papers (2015–2017)Anders Bergh · Thomas Jefferson University4 papers (2014–2016)Anders Widmark · Umeå University4 papers (2015–2017)Stefan Carlsson · Karolinska University Hospital4 papers (2012–2015)Tanja Stocks · Lund University3 papers (2012–2024)Fredrik Sandin · Regional Cancer Center3 papers (2012–2017)